IRIS

ROSSI, DANIELA

ROSSI, DANIELA  

DIPARTIMENTO DI SCIENZE DEL FARMACO  

Mostra records
Risultati 1 - 20 di 156 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autore(i) File
(R)-(-)-Aloesaponol III 8-methyl ether from eremurus persicus: A novel compound against leishmaniosis 1-gen-2017 Rossi, Daniela; AL JAMMOOREE, KARZAN MAHMOOD AHMED; Gaggeri, RAFFAELLA FRANCESCA; DELLA VOLPE, Serena; Maggi, Lauretta; Mazzeo, Giuseppe; Longhi, Giovanna; Abbate, Sergio; Corana, Federica; Martino, Emanuela; Machad, Marisa; Varandas, Raquel; do Céu Sousa, Maria; Collina, Simona
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 1-gen-2014 Rossi, Daniela; Marra, Annamaria; Erik, Laurini; Sabrina, Pricl; Dirk, Schepmann; Bernhard, Wuensch; Peviani, Marco; Curti, Daniela; Collina, Simona
3-Piperidin-4-ylmethyl-3H-benzoxazol-2-one derivatives as sigma ligands 1-gen-2007 Mamolo Maria, Grazia; Zampieri, Daniele; Laurini, Erik; Vio, Luciano; Collina, Simona; Rossi, Daniela; Azzolina, Ornella; Florio, Chiara; Zanette, Caterina
3D pharmacophore model of sigma1 binding site based on a series of subtitued benzo[d]oxazol-2(3H)-one derivatives. 1-gen-2008 Erik, Laurini; Maria Grazia, Mamolo; Daniele, Zampieri; Chiara, Florio; Caterina, Zanette; Sabrina, Pricl; Maurizio, Fermeglia; Maria Silvia, Panemi; Collina, Simona; Rossi, Daniela; Luciano, Vio
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 1-gen-2015 Rossi, Daniela; Marra, Annamaria; Rui, Marta; Erik, Laurini; Maurizio, Fermeglia; Sabrina, Pricl; Dirk, Schepmann; Bernhard, Wuensch; Peviani, Marco; Curti, Daniela; Collina, Simona
A step forward in the sigma enigma: the role of chirality in the interaction ligand-sigma1 receptor 1-gen-2014 Marra, Annamaria; Erik, Laurini; Rossi, Daniela; Azzolina, Ornella; Sabrina, Pricl; Collina, Simona
A step forward in understanding the binding of ELAV mimicking peptides to mRNA. An integrated computational and NMR approach 1-gen-2013 Rossi, Daniela; Marra, Annamaria; Gaggeri, RAFFAELLA FRANCESCA; Amadio, Marialaura; Pascale, ALESSIA ANGELA; Govoni, Stefano; Laurini, E.; Pricl, S.; Vasile, F.; Alberti, E.; Potenza, D.; Collina, Simona
An Analytical and Scale-Up Separation by HPLC and SFC of theFlavonoid Naringenin on a RegisPack® Chiral Stationary Phase 1-gen-2010 Ted, Szczerba; Zahid, Ali; Gaggeri, RAFFAELLA FRANCESCA; Rossi, Daniela; Collina, Simona; Mannucci, Barbara; Stefanie, Abel; Doris, Frühauf; Markus, Juza
An eco-friendly enantioselective access to (R)-Naringenin as inhibitor of proinflammatory cytokine release. 1-gen-2013 Gaggeri, RAFFAELLA FRANCESCA; Rossi, Daniela; Daglia, Maria; Leoni, F; Avanzini, Ma; Mantelli, M; Juza, M; Collina, Simona
An efficient procedure based on MW-assisted Horner–Wadsworth-Emmons reaction for the synthesis of (Z)-3,3-trisubstituted alpha, beta-unsaturated esters 1-gen-2010 Rossi, Daniela; CARNEVALE BARAGLIA, ANNA CATERINA; Serra, Massimo; Azzolina, Ornella; Collina, Simona
Anti-inflammatory properties of ethanolic root extract of Eremurus persicus (Jaub and Spach) Boiss, a Kurdish herbal remedy 1-gen-2013 Gaggeri, RAFFAELLA FRANCESCA; Rossi, Daniela; Azzolina, Ornella; Mahmood, K; Avanzini, A; Mantelli, M; Gozzini, Davide; Paolillo, Mayra; Collina, Simona
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 1-gen-2019 Tesei, A.; Cortesi, M.; Pignatta, S.; Arienti, C.; Massimo Dondio, G.; Bigogno, C.; Malacrida, A.; Miloso, M.; Meregalli, C.; Chiorazzi, A.; Carozzi, V.; Cavaletti, G.; Rui, M.; Marra, A.; Rossi, D.; Collina, S.
Antibacterial activity of Amygdalus Lycioides (Spach.): screening of different branch extracts 1-gen-2008 Gaggeri, RAFFAELLA FRANCESCA; Collina, Simona; Rossi, Daniela; Martino, Emanuela; Grisoli, Pietro; Dacarro, Cesare; Azzolina, Ornella
Approaches for multi-gram scale isolation of enantiomers for drug discovery 1-gen-2017 Rossi, D.; Tarantino, M.; Rossino, G.; Rui, M.; Juza, M.; Collina, S.
Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). 1-gen-2017 Collina, Simona; Bignardi, Emanuele; Rui, Marta; Rossi, Daniela; Gaggeri, R; Zamagni, A; Cortesi, M; Tesei, A.
Are sigma receptor modulators a weapon against multiple sclerosis disease? 1-gen-2017 Collina, S.; Rui, M.; Stotani, Silvia; Bignardi, E.; Rossi, D.; Curti, D.; Giordanetto, F.; Malacrida, A.; Scuteri, A.; Cavaletti, G.
ARE we stable? An integrated in vitro/in silico approach for the study of Embryonic Lethal Abnormal Vision protein and mRNA interactions. 1-gen-2012 Amadio, Marialaura; Osera, Cecilia; Gaggeri, RAFFAELLA FRANCESCA; Laurini, E.; Pricl, S.; Rossi, Daniela; Collina, Simona; Pascale, ALESSIA ANGELA
Beyond the affinity for protein kinase C: Exploring 2-phenyl-3-hydroxypropyl pivalate analogues as C1 domain-targeting ligands 1-gen-2015 Rossi, Daniela; Talman, V.; Gennäs, G. B. A.; Marra, Annamaria; Picconi, Pietro; Nasti, Rita; Serra, Massimo; Ann, J.; Amadio, Marialaura; Pascale, ALESSIA ANGELA; Tuominen, R. K.; Yli Kauhaluoma, J.; Lee, J.; Collina, Simona
Beyond the affinity for the Protein Kinase C: a critical evaluation of 2-fenil-3hydroxypropyl pivalate analogs targeting the C1 domain 1-gen-2015 Nasti, Rita; Marra, Annamaria; Boije Gennäs, G; Talaman, V; Yli Kauhaluoma, J; Tuominen, R. K; Lee, J; Rossi, Daniela; Collina, Simona
Binding Studies and Quantitative Structure-Activity Relationship of 3-Amino-1H-Indazoles as Inhibitors of GSK3beta 1-gen-2011 Caballero, J; Zilocchi, S; Tiznado, W; Collina, Simona; Rossi, Daniela